Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically

Journal of Midwifery & Women's Health
Anne BaggleyAdrienne Einarson

Abstract

Nausea and vomiting of pregnancy (NVP) affects up to 80% of all women to some degree during their pregnancies. Diclectin (doxylamine and pyridoxine [vitamin B6]) has been on the Canadian market for many years and is indicated as the drug of choice for the treatment of NVP. However, some women choose not to treat NVP with pharmacologic measures, perhaps due to a persistent fear of teratogenic risk. The objective of this study was to determine the factors that influence a woman's decision not to treat NVP with pharmacologic measures. Fifty-nine women recruited from the Motherisk Nausea and Vomiting Helpline completed a questionnaire. All were informed that Diclectin was considered safe for use during pregnancy. At a follow-up telephone call, 34% were not using any pharmacologic treatment, and of those who were taking the drug, 26% were using less than the recommended dose. Reasons cited for not using the medication were insufficient safety data, preference for non-pharmacologic methods, and being made to feel uncomfortable by the physician. Of the women who did use Diclectin, the most convincing reassuring information that it was safe to use came from friends and family. Many other factors play a large role in a women's decision ...Continue Reading

References

Jan 4, 1991·European Journal of Obstetrics, Gynecology, and Reproductive Biology·W Fischer-RasmussenU Asping
Oct 1, 1988·Drug Intelligence & Clinical Pharmacy·T R EinarsonG Koren
Apr 14, 2000·American Journal of Obstetrics and Gynecology·R LacroixR Melzack
May 5, 2000·The Cochrane Database of Systematic Reviews·D Jewell, G Young
Oct 21, 2000·American Journal of Perinatology·R EliakimD M Sherer
Nov 15, 2000·Journal of Psychosomatic Obstetrics and Gynaecology·P MazzottaL A Magee
Apr 25, 2001·Journal of Psychosomatic Obstetrics and Gynaecology·P MazzottaL A Magee
May 16, 2002·American Journal of Obstetrics and Gynecology·Cheryl L AttardGeorge W Torrance
May 16, 2002·American Journal of Obstetrics and Gynecology·Gideon Koren, Zina Levichek
May 16, 2002·American Journal of Obstetrics and Gynecology·Robert Brent
May 30, 2002·BMC Complementary and Alternative Medicine·Taras HollyerAdrienne Einarson
Mar 15, 2003·Gastroenterology Clinics of North America·Kenneth L Koch, Christine L Frissora
Oct 30, 2003·The Cochrane Database of Systematic Reviews·D Jewell, G Young
Nov 25, 2003·American Journal of Obstetrics and Gynecology·Galina PortnoiLinda Karimi-Tabesh

❮ Previous
Next ❯

Citations

Oct 19, 2013·Medicine, Conflict, and Survival·Cindy A Sousa
Feb 12, 2013·Iranian Red Crescent Medical Journal·Mojgan Naeimi RadShahla Yazdani
Feb 12, 2013·Iranian Red Crescent Medical Journal·Hajar PashaAli Akbar Moghadamnia
Dec 1, 2006·Archives of Gynecology and Obstetrics·Gertraud E MarklJoerg Hasford
Feb 9, 2016·Scandinavian Journal of Primary Health Care·Kristine HeitmannLone Holst
Sep 2, 2006·Pharmacotherapy·Martina L BadellJudith A Smith
Jun 8, 2006·Scandinavian Journal of Caring Sciences·Annelie Agren, Marie Berg
Dec 5, 2014·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Noha M Zaki, Ahmed A Albarraq
Nov 3, 2009·Journal of Midwifery & Women's Health·Tekoa L King, Patricia Aikins Murphy
Dec 3, 2014·The Nursing Clinics of North America·Fiona Bath-Hextall
Mar 28, 2006·Reproductive Toxicology·Adrienne Einarson, Donna Lockett
Aug 26, 2010·The Annals of Pharmacotherapy·Hedvig NordengAdrienne Einarson
Sep 29, 2011·Birth Defects Research. Part A, Clinical and Molecular Teratology·Ilan Shahin, Adrienne Einarson
Mar 16, 2013·Journal of Advanced Nursing·Kathleen M StepanukAnand Bhattacharya
Aug 14, 2018·Depression and Anxiety·Catriona Hippman, Lynda G Balneaves
Nov 14, 2019·International Journal of Clinical Pharmacy·Gesnita NugraheniElida Zairina
Oct 24, 2020·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Yael LurieDaniel Kurnik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.